Predictors | Area | se | p-value | 95% CI of area | Cut-off point¶ | Sensitivity | Specificity | Positive predictive value | Negative predictive value | Likelihood ratio of a positive test result | Likelihood ratio of a negative test result |
GOLD stages | 0.823 | 0.035 | <0.001 | 0.76–0.89 | III | 0.80 | 0.75 | 0.69 | 0.85 | 3.25 | 0.26 |
BODE score | 0.796 | 0.036 | <0.001 | 0.73–0.87 | 3 | 0.67 | 0.79 | 0.69 | 0.78 | 3.23 | 0.42 |
FEV1 % pred | 0.795 | 0.036 | <0.001 | 0.73–0.87 | 54 | 0.80 | 0.71 | 0.65 | 0.84 | 2.78 | 0.28 |
6MWD m | 0.773 | 0.037 | <0.001 | 0.70–0.85 | 44 | 0.79 | 0.74 | 0.68 | 0.84 | 3.06 | 0.29 |
MMRC grade | 0.768 | 0.037 | <0.001 | 0.70–0.84 | 2 | 0.65 | 0.78 | 0.67 | 0.77 | 3.01 | 0.44 |
CI: confidence interval; GOLD: Global Initiative for Chronic Obstructive Lung Disease; BODE: body mass index, airway obstruction, dyspnoea, exercise capacity; FEV1: forced expiratory volume in one second; % pred: % predicted; 6MWD: 6-min walk distance; MMRC: modified Medical Research Council dyspnoea scale. #: defined as a physical activity level <1.40, including 66 patients with COPD (40.5% of all COPD patients); ¶: equal or greater than.